Literature DB >> 35650276

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Emily Latacz1, Diederik Höppener2, Ali Bohlok3, Vincent Donckier3, Peter M Siegel4,5, Raymond Barnhill6,7, Marco Gerling8,9, Cornelis Verhoef2, Peter B Vermeulen10, Sophia Leduc11, Sébastien Tabariès4, Carlos Fernández Moro12,13, Claire Lugassy6, Hanna Nyström14,15, Béla Bozóky13, Giuseppe Floris16,17, Natalie Geyer8, Pnina Brodt18, Laura Llado19, Laura Van Mileghem1, Maxim De Schepper11, Ali W Majeed20, Anthoula Lazaris21, Piet Dirix1, Qianni Zhang22, Stéphanie K Petrillo21, Sophie Vankerckhove3, Ines Joye1, Yannick Meyer2, Alexander Gregorieff21,23,24, Nuria Ruiz Roig25,26,27, Fernando Vidal-Vanaclocha28, Larsimont Denis29, Rui Caetano Oliveira30,31,32, Peter Metrakos21, Dirk J Grünhagen2, Iris D Nagtegaal33, David G Mollevi26,34, William R Jarnagin35, Michael I D'Angelica35, Andrew R Reynolds36, Michail Doukas37, Christine Desmedt11, Luc Dirix1.   

Abstract

The first consensus guidelines for scoring the histopathological growth patterns (HGPs) of liver metastases were established in 2017. Since then, numerous studies have applied these guidelines, have further substantiated the potential clinical value of the HGPs in patients with liver metastases from various tumour types and are starting to shed light on the biology of the distinct HGPs. In the present guidelines, we give an overview of these studies, discuss novel strategies for predicting the HGPs of liver metastases, such as deep-learning algorithms for whole-slide histopathology images and medical imaging, and highlight liver metastasis animal models that exhibit features of the different HGPs. Based on a pooled analysis of large cohorts of patients with liver-metastatic colorectal cancer, we propose a new cut-off to categorise patients according to the HGPs. An up-to-date standard method for HGP assessment within liver metastases is also presented with the aim of incorporating HGPs into the decision-making processes surrounding the treatment of patients with liver-metastatic cancer. Finally, we propose hypotheses on the cellular and molecular mechanisms that drive the biology of the different HGPs, opening some exciting preclinical and clinical research perspectives.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35650276      PMCID: PMC9470557          DOI: 10.1038/s41416-022-01859-7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   9.075


  124 in total

Review 1.  Vascularizing organogenesis: Lessons from developmental biology and implications for regenerative medicine.

Authors:  Edward Daniel; Ondine Cleaver
Journal:  Curr Top Dev Biol       Date:  2019-01-18       Impact factor: 4.897

2.  Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases.

Authors:  Kimberly H Allison; Corinne L Fligner; W Tony Parks
Journal:  Arch Pathol Lab Med       Date:  2004-12       Impact factor: 5.534

Review 3.  The portal fibroblast: not just a poor man's stellate cell.

Authors:  Rebecca G Wells
Journal:  Gastroenterology       Date:  2014-05-09       Impact factor: 22.682

Review 4.  The role of the pathologist and clinical implications in colorectal liver metastasis.

Authors:  P Baldin; M Van den Eynde; C Hubert; A Jouret-Mourin; M Komuta
Journal:  Acta Gastroenterol Belg       Date:  2018 Jul-Sep       Impact factor: 1.316

5.  The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.

Authors:  Amalia Raluca Ceausu; Alexandru Ciolofan; Anca Maria Cimpean; Adina Magheti; Ovidiu Mederle; Marius Raica
Journal:  Anticancer Res       Date:  2018-02       Impact factor: 2.480

6.  Radiographically occult intrasinusoidal liver metastases leading to hepatic failure in a case of breast cancer.

Authors:  Seema Gulia; Sachin Khurana; Tanuja Shet; Sudeep Gupta
Journal:  BMJ Case Rep       Date:  2016-02-15

Review 7.  Vessel co-option and resistance to anti-angiogenic therapy.

Authors:  Elizabeth A Kuczynski; Andrew R Reynolds
Journal:  Angiogenesis       Date:  2019-12-21       Impact factor: 9.596

8.  Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.

Authors:  Pieter M H Nierop; Boris Galjart; Diederik J Höppener; Eric P van der Stok; Robert R J Coebergh van den Braak; Peter B Vermeulen; Dirk J Grünhagen; Cornelis Verhoef
Journal:  Clin Exp Metastasis       Date:  2019-03-06       Impact factor: 5.150

9.  Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.

Authors:  Pieter Mh Nierop; Diederik J Höppener; Florian E Buisman; Eric P van der Stok; Boris Galjart; Vinod P Balachandran; William R Jarnagin; T Peter Kingham; Jinru Shia; Murielle Mauer; Bernard Nordlinger; Catherine Julié; Bas Groot Koerkamp; Michail Doukas; Peter B Vermeulen; Dirk J Grünhagen; Michael I D'Angelica; Cornelis Verhoef
Journal:  J Pathol Clin Res       Date:  2021-09-04

Review 10.  Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes.

Authors:  Fernando Vidal-Vanaclocha; Olatz Crende; Cira García de Durango; Alejandro Herreros-Pomares; Sandra López-Doménech; Álvaro González; Eva Ruiz-Casares; Thierry Vilboux; Riccardo Caruso; Hipólito Durán; Antonio Gil; Benedetto Ielpo; Fernando Lapuente; Yolanda Quijano; Emilio Vicente; Leticia Vidal-Lartitegui; Eduardo M Sotomayor
Journal:  Semin Cancer Biol       Date:  2020-08-15       Impact factor: 15.707

View more
  2 in total

Review 1.  CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.

Authors:  Shenglin Li; Zhengxiao Li; Xiaoyu Huang; Peng Zhang; Juan Deng; Xianwang Liu; Caiqiang Xue; Wenjuan Zhang; Junlin Zhou
Journal:  Abdom Radiol (NY)       Date:  2022-07-27

2.  Gene Alterations, Mediators, and Artificial Intelligence in Colorectal Liver Metastases.

Authors:  Doris Wagner; Georgios Antonios Margonis
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.